Brighton Jones LLC Abbott Laboratories Transaction History

Brighton Jones LLC

  • $2.55 Billion
  • Q3 2024

A detailed history of Brighton Jones LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Brighton Jones LLC holds 46,964 shares of ABT stock, worth $5.39 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
46,964
Previous 15,170 209.58%
Holding current value
$5.39 Million
Previous $1.58 Million 239.72%
% of portfolio
0.21%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
BUY
$100.07 - $118.13 $3.18 Million - $3.76 Million
31,794 Added 209.58%
46,964 $5.35 Million
Q2 2024

Aug 12, 2024
BUY
$100.73 - $112.44 $1,712 - $1,911
17 Added 0.11%
15,170 $1.58 Million
Q1 2024

May 09, 2024
BUY
$109.52 - $120.96 $54,869 - $60,600
501 Added 3.42%
15,153 $1.72 Million
Q4 2023

Feb 05, 2024
SELL
$90.19 - $110.4 $1,803 - $2,208
-20 Reduced 0.14%
14,652 $1.61 Million
Q3 2023

Oct 25, 2023
BUY
$95.53 - $114.62 $116,642 - $139,951
1,221 Added 9.08%
14,672 $1.42 Million
Q2 2023

Jul 31, 2023
SELL
$100.78 - $112.29 $2,721 - $3,031
-27 Reduced 0.2%
13,451 $1.47 Million
Q1 2023

May 08, 2023
SELL
$96.86 - $114.01 $73,032 - $85,963
-754 Reduced 5.3%
13,478 $1.36 Million
Q4 2022

Feb 02, 2023
BUY
$95.06 - $111.52 $109,509 - $128,471
1,152 Added 8.81%
14,232 $1.56 Million
Q3 2022

Nov 09, 2022
BUY
$96.76 - $112.03 $37,059 - $42,907
383 Added 3.02%
13,080 $1.27 Million
Q2 2022

Aug 04, 2022
SELL
$102.07 - $123.37 $64,916 - $78,463
-636 Reduced 4.77%
12,697 $1.38 Million
Q1 2022

May 13, 2022
SELL
$114.02 - $139.04 $5,815 - $7,091
-51 Reduced 0.38%
13,333 $1.58 Million
Q4 2021

Feb 03, 2022
BUY
$115.53 - $141.46 $76,249 - $93,363
660 Added 5.19%
13,384 $1.88 Million
Q3 2021

Nov 04, 2021
BUY
$116.66 - $129.06 $14,349 - $15,874
123 Added 0.98%
12,724 $1.5 Million
Q2 2021

Aug 10, 2021
SELL
$105.79 - $124.53 $165,455 - $194,764
-1,564 Reduced 11.04%
12,601 $1.46 Million
Q1 2021

May 07, 2021
BUY
$108.84 - $128.23 $150,961 - $177,855
1,387 Added 10.85%
14,165 $1.7 Million
Q4 2020

Feb 10, 2021
SELL
$105.0 - $114.42 $280,035 - $305,158
-2,667 Reduced 17.27%
12,778 $1.4 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $269,879 - $327,749
2,945 Added 23.56%
15,445 $1.68 Million
Q2 2020

Aug 11, 2020
BUY
$76.57 - $98.0 $90,812 - $116,228
1,186 Added 10.48%
12,500 $1.14 Million
Q1 2020

May 13, 2020
SELL
$62.82 - $91.86 $19,976 - $29,211
-318 Reduced 2.73%
11,314 $893,000
Q4 2019

Feb 07, 2020
BUY
$78.51 - $87.4 $44,515 - $49,555
567 Added 5.12%
11,632 $1.01 Million
Q3 2019

Oct 28, 2019
BUY
$81.84 - $88.74 $82,985 - $89,982
1,014 Added 10.09%
11,065 $926,000
Q2 2019

Aug 05, 2019
BUY
$72.88 - $85.0 $14,138 - $16,490
194 Added 1.97%
10,051 $845,000
Q1 2019

Apr 26, 2019
SELL
$66.22 - $80.06 $27,415 - $33,144
-414 Reduced 4.03%
9,857 $788,000
Q4 2018

Feb 08, 2019
SELL
$65.56 - $74.27 $8,457 - $9,580
-129 Reduced 1.24%
10,271 $743,000
Q3 2018

Nov 07, 2018
BUY
$60.81 - $73.36 $34,418 - $41,521
566 Added 5.76%
10,400 $763,000
Q2 2018

Aug 06, 2018
BUY
$57.57 - $63.54 $93,781 - $103,506
1,629 Added 19.85%
9,834 $600,000
Q1 2018

May 03, 2018
SELL
$56.27 - $63.62 $10,916 - $12,342
-194 Reduced 2.31%
8,205 $492,000
Q4 2017

Feb 08, 2018
BUY
$53.68 - $57.47 $29,577 - $31,665
551 Added 7.02%
8,399 $479,000
Q3 2017

Nov 08, 2017
SELL
$48.06 - $53.64 $11,294 - $12,605
-235 Reduced 2.91%
7,848 $419,000
Q2 2017

Aug 08, 2017
BUY
N/A
8,083
8,083 $393,000

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email